Hormel Foods Corporation reported preliminary first quarter fiscal 2026 results, expecting net sales of approximately $3 billion and reaffirming its fiscal 2026 guidance. The company also announced a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations, with minimal estimated impact on its 2026 financial guidance. These moves are part of Hormel’s portfolio shaping efforts and reflect a solid start to the year, aiming for long-term profitable growth.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hormel (NYSE: HRL) posts Q1 prelims and sells whole-bird turkey unit
Hormel Foods Corporation reported preliminary first quarter fiscal 2026 results, expecting net sales of approximately $3 billion and reaffirming its fiscal 2026 guidance. The company also announced a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations, with minimal estimated impact on its 2026 financial guidance. These moves are part of Hormel’s portfolio shaping efforts and reflect a solid start to the year, aiming for long-term profitable growth.